| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2026 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R43DK146593 | An intracorporeal hemodialysis system (iHemo) enabling home hemodialysis | 000 | 1 | NIH | 10/21/2026 | $0 |
|
| Issue Date FY: 2026 ( Subtotal = $354,500 ) |
| | 2026 | 2026 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R43DK146593 | An intracorporeal hemodialysis system (iHemo) enabling home hemodialysis | 000 | 1 | NIH | 8/25/2026 | $354,500 |
| | 2026 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 4 | NIH | 6/30/2026 | $0 |
| | 2026 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 001 | 4 | NIH | 8/17/2026 | $0 |
| | 2026 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 001 | 4 | NIH | 8/17/2026 | $0 |
| | 2026 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 4 | NIH | 6/30/2026 | $0 |
| | 2026 | 2024 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R43DK139811 | The intracorporeal hemodialysis system (iHemo) for eliminating the mortality health disparity of rural and remote End-stage Kidney Disease patients | 000 | 1 | NIH | 8/31/2026 | $0 |
| | 2026 | 2024 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK120242 | A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | 000 | 3 | NIH | 7/30/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $1,000,000 ) |
| | 2025 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 001 | 4 | NIH | 9/22/2025 | $202,562 |
| | 2025 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 4 | NIH | 7/30/2025 | $400,000 |
| | 2025 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 001 | 4 | NIH | 9/22/2025 | -$202,562 |
| | 2025 | 2025 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 4 | NIH | 7/30/2025 | $600,000 |
| | 2025 | 2024 | SILICON KIDNEY LLC | 255 KANSAS ST STE 300 | SAN FRANCISCO | CA | 94103-5106 | SAN FRANCISCO | USA | R43DK139811 | The intracorporeal hemodialysis system (iHemo) for eliminating the mortality health disparity of rural and remote End-stage Kidney Disease patients | 000 | 1 | NIH | 6/25/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,276,459 ) |
| | 2024 | 2024 | SILICON KIDNEY LLC | 101 MISSISSIPPI ST | SAN FRANCISCO | CA | 94107-2523 | SAN FRANCISCO | USA | R44DK120242 | A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | 000 | 3 | NIH | 2/29/2024 | $1,019,958 |
| | 2024 | 2024 | SILICON KIDNEY LLC | 101 MISSISSIPPI ST | SAN FRANCISCO | CA | 94107-2523 | SAN FRANCISCO | USA | R43DK139811 | The intracorporeal hemodialysis system (iHemo) for eliminating the mortality health disparity of rural and remote End-stage Kidney Disease patients | 000 | 1 | NIH | 4/26/2024 | $256,501 |
| | 2024 | 2019 | SILICON KIDNEY LLC | 101 MISSISSIPPI ST | SAN FRANCISCO | CA | 94107-2523 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 3 | NIH | 2/13/2024 | $0 |
| | 2024 | 2019 | SILICON KIDNEY LLC | 101 MISSISSIPPI ST | SAN FRANCISCO | CA | 94107-2523 | SAN FRANCISCO | USA | R43DK123775 | A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | 000 | 1 | NIH | 3/4/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,019,979 ) |
| | 2023 | 2023 | SILICON KIDNEY LLC | 1700 4TH ST | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R44DK120242 | A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | 000 | 2 | NIH | 2/13/2023 | $1,019,979 |
| | 2023 | 2019 | SILICON KIDNEY LLC | 101 MISSISSIPPI ST | SAN FRANCISCO | CA | 94107-2523 | SAN FRANCISCO | USA | R43DK120242 | A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | 000 | 1 | NIH | 9/8/2023 | $0 |
| | 2023 | 2019 | SILICON KIDNEY LLC | 101 MISSISSIPPI ST | SAN FRANCISCO | CA | 94107-2523 | SAN FRANCISCO | USA | R44DK102240 | An implantable hemodialyzer for treatment of End-stage Renal Disease | 000 | 3 | NIH | 4/10/2023 | $0 |
| | 2023 | 2019 | SILICON KIDNEY LLC | 1700 4TH ST | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R43DK123775 | A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | 000 | 1 | NIH | 10/25/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 3 | NIH | 8/17/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 3 | NIH | 6/30/2021 | $0 |
| | 2021 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R43DK123775 | A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | 000 | 1 | NIH | 9/14/2021 | $0 |
| | 2021 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R43DK120242 | A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | 000 | 1 | NIH | 8/12/2021 | $0 |
| | 2021 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R44DK102240 | An implantable hemodialyzer for treatment of End-stage Renal Disease | 000 | 3 | NIH | 6/24/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $51,360 ) |
| | 2020 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R44DK102240 | An implantable hemodialyzer for treatment of End-stage Renal Disease | 000 | 3 | NIH | 6/10/2020 | $51,360 |
| | 2020 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R43DK123775 | A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | 000 | 1 | NIH | 5/7/2020 | $0 |
| | 2020 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94143-2330 | SAN FRANCISCO | USA | R43DK120242 | A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | 000 | 1 | NIH | 9/14/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,955,656 ) |
| | 2019 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 3 | NIH | 7/19/2019 | $746,229 |
| | 2019 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R44DK102240 | An implantable hemodialyzer for treatment of End-stage Renal Disease | 000 | 3 | NIH | 7/25/2019 | $686,850 |
| | 2019 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R43DK123775 | A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | 000 | 1 | NIH | 9/19/2019 | $298,388 |
| | 2019 | 2019 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R43DK120242 | A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | 000 | 1 | NIH | 9/19/2019 | $224,189 |
|
| Issue Date FY: 2018 ( Subtotal = $1,503,244 ) |
| | 2018 | 2018 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R44DK104299 | An intravascular Bioartificial Pancreas (iBAP) | 000 | 2 | NIH | 7/11/2018 | $746,324 |
| | 2018 | 2018 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R44DK102240 | An implantable hemodialyzer for treatment of End-stage Renal Disease | 000 | 2 | NIH | 9/15/2018 | $756,920 |
| | 2018 | 2014 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R43DK104299 | An Intravascular Bioartificial Pancreas (iBAP) | 000 | 1 | NIH | 2/12/2018 | $0 |
| | 2018 | 2014 | SILICON KIDNEY | 1700 4TH ST ROOM 219 | SAN FRANCISCO | CA | 94153-2330 | | USA | R43DK102240 | An implantable hemodialyzer for treatment of End-Stage Renal Disease | 000 | 1 | NIH | 1/29/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2014 | SILICON KIDNEY | 1452 5TH AVE | SAN FRANCISCO | CA | 94122-3807 | SAN FRANCISCO | USA | R43DK102240 | An implantable hemodialyzer for treatment of End-Stage Renal Disease | 000 | 1 | NIH | 1/16/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $0 ) (Continued on the next page) |
|
